T 0007/07 (Ethinylestradiol and drospirenone for use as a contraceptive/BAYER PHARMA AG) of 07.07.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T000707.20110707
- Date of decision
- 7 July 2011
- Case number
- T 0007/07
- Petition for review of
- -
- Application number
- 00953387.8
- IPC class
- A61K 31/565A61K 31/585A61P 15/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
- Applicant name
- Bayer Pharma Aktiengesellschaft
- Opponent name
- Hexal AG
Intervener:
Ladee Pharma Baltics UAB - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- Agreement on Trade-Related Aspects of Intellectual Property Rights Art 39European Patent Convention Art 105(1)(a)European Patent Convention Art 115European Patent Convention Art 2(1) 1973European Patent Convention Art 3 1973European Patent Convention Art 54 1973European Patent Convention R 64(a) 1973Lithuanian Patent Law Art 50
- Keywords
- Admissibility of the appeal (yes): appellant clearly identifyable
Admissibility of the intervention (no): infringement proceedings instituted in extension state not based on the European patent in suit
Admissibility of auxiliary request 3 (no): prima facie clarity problems
Novelty of main request and auxiliary request 1 (no): not novel over public prior use
Auxiliary request 2 - Article 123(2) EPC (no): new combination of features - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.